- Home
- AAP vs PTGX Comparison
AAP vs PTGX Comparison
Compare AAP & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- PTGX
- Stock Information
- Founded
- AAP 1929
- PTGX 2006
- Country
- AAP United States
- PTGX United States
- Employees
- AAP N/A
- PTGX N/A
- Industry
- AAP Auto & Home Supply Stores
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AAP Consumer Discretionary
- PTGX Health Care
- Exchange
- AAP Nasdaq
- PTGX Nasdaq
- Market Cap
- AAP 3.7B
- PTGX 4.0B
- IPO Year
- AAP N/A
- PTGX 2016
- Fundamental
- Price
- AAP $57.04
- PTGX $65.23
- Analyst Decision
- AAP Hold
- PTGX Strong Buy
- Analyst Count
- AAP 19
- PTGX 8
- Target Price
- AAP $52.34
- PTGX $71.13
- AVG Volume (30 Days)
- AAP 1.7M
- PTGX 1.0M
- Earning Date
- AAP 11-13-2025
- PTGX 11-06-2025
- Dividend Yield
- AAP 1.76%
- PTGX N/A
- EPS Growth
- AAP N/A
- PTGX N/A
- EPS
- AAP N/A
- PTGX 0.80
- Revenue
- AAP $8,737,327,000.00
- PTGX $209,180,000.00
- Revenue This Year
- AAP N/A
- PTGX N/A
- Revenue Next Year
- AAP $1.10
- PTGX $248.17
- P/E Ratio
- AAP N/A
- PTGX $81.41
- Revenue Growth
- AAP N/A
- PTGX N/A
- 52 Week Low
- AAP $28.89
- PTGX $33.31
- 52 Week High
- AAP $70.00
- PTGX $68.26
- Technical
- Relative Strength Index (RSI)
- AAP 41.01
- PTGX 58.33
- Support Level
- AAP $60.57
- PTGX $63.71
- Resistance Level
- AAP $62.85
- PTGX $66.87
- Average True Range (ATR)
- AAP 2.22
- PTGX 2.53
- MACD
- AAP -0.46
- PTGX -0.19
- Stochastic Oscillator
- AAP 6.04
- PTGX 63.47
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.